Filing Details
- Accession Number:
- 0001203311-20-000122
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-05 20:44:48
- Reporting Period:
- 2020-11-03
- Accepted Time:
- 2020-11-05 20:44:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202794 | E Marc Lippman | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-03 | 9,260 | $56.77 | 140,908 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 9,260 | $168.45 | 131,648 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 9,260 | $38.82 | 140,908 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 9,260 | $168.42 | 131,648 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 9,260 | $39.94 | 140,908 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 9,260 | $168.39 | 131,648 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 8,750 | $34.25 | 140,398 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 8,750 | $168.32 | 131,648 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 8,750 | $36.70 | 140,398 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 8,750 | $168.11 | 131,648 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 4,716 | $20.06 | 136,364 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 4,716 | $167.97 | 131,648 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 12,784 | $20.06 | 144,432 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 12,784 | $167.10 | 131,648 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-03 | 65,246 | $168.89 | 66,402 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-03 | 14,064 | $169.80 | 52,338 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 4,716 | $0.00 | 4,716 | $20.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 12,784 | $0.00 | 12,784 | $20.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 8,750 | $0.00 | 8,750 | $34.25 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 8,750 | $0.00 | 8,750 | $36.70 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 9,260 | $0.00 | 9,260 | $38.82 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 9,260 | $0.00 | 9,260 | $39.94 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 9,260 | $0.00 | 9,260 | $56.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,784 | 2022-05-17 | No | 4 | M | Direct | |
| 0 | 2022-05-17 | No | 4 | M | Direct | |
| 0 | 2024-05-15 | No | 4 | M | Direct | |
| 0 | 2023-05-17 | No | 4 | M | Direct | |
| 0 | 2026-05-19 | No | 4 | M | Direct | |
| 0 | 2025-05-14 | No | 4 | M | Direct | |
| 0 | 2028-05-18 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $168.42 to $168.52. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $168.37 to $168.42. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $168.23 to $168.37. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $168.04 to $168.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $167.80 to $168.04. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $166.76 to $167.62 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $168.52 to $169.51. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $169.61 to $170.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options were fully vested on 5/17/13.
- Options were fully vested on 5/15/15.
- Options were fully vested on 5/16/14.
- Options were fully vested on 5/19/17.
- Options were fully vested on 5/14/16.
- Options were fully vested on 5/18/19.
Billionaire Hedge Funds
